EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti‐inflammatory compounds to reduce infarct size in large‐animal models of myocardial infarction: A meta‐analysis

G.P.J. van Hout, S.J. Jansen of Lorkeers, K.E. Wever, E.S. Sena, W.W. van Solinge, P.A. Doevendans, G. Pasterkamp, S.A.J. Chamuleau, I.E. Hoefer

Evidence-based Preclinical Medicine · 2014

DOI: 10.1002/ebm2.4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Evidence-based Preclinical Medicine, 2014. Verfasst von G.P.J. van Hout und 8 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting the inflammatory response after myocardial infarction ( MI ) could potentially prevent infarct expansion, resulting in a preservation of cardiac function. Despite extensive testing in large‐animal models of MI , anti‐inflammatory therapeutics are not incorporated in daily clinical practice. Methodological review of the literature describing the effects of anti‐inflammatory compounds in large‐animal models of MI may provide useful insights into the reasons for the translational failure from preclinical to clinical studies. Moreover, systematic review of these preclinical studies may allow us to determine which anti‐inflammatory agents have the greatest potential to successfully treat MI in the clinic and guide which preclinical setting appears most appropriate to test these future treatment strategies in. The current systematic review protocol provides a detailed description of the design of this systematic review of studies investigating the effects of anti‐inflammatory compounds in large‐animal models of MI .

Zitieren

APA

Hout, G. V., Lorkeers, S. J. O., Wever, K., Sena, E., Solinge, W. V., Doevendans, P., Pasterkamp, G., Chamuleau, S., & Hoefer, I. (2014). Anti‐inflammatory compounds to reduce infarct size in large‐animal models of myocardial infarction: A meta‐analysis. Evidence-based Preclinical Medicine. https://doi.org/10.1002/ebm2.4

Vancouver

Hout GV, Lorkeers SJO, Wever K, Sena E, Solinge WV, Doevendans P, et al. Anti‐inflammatory compounds to reduce infarct size in large‐animal models of myocardial infarction: A meta‐analysis. Evidence-based Preclinical Medicine. 2014. doi:10.1002/ebm2.4

BibTeX
@article{Hout2014,
  author = {Hout, G.P.J. van and Lorkeers, S.J. Jansen of and Wever, K.E. and Sena, E.S. and Solinge, W.W. van and Doevendans, P.A. and Pasterkamp, G. and Chamuleau, S.A.J. and Hoefer, I.E.},
  title = {Anti‐inflammatory compounds to reduce infarct size in large‐animal models of myocardial infarction: A meta‐analysis},
  journal = {Evidence-based Preclinical Medicine},
  year = {2014},
  doi = {10.1002/ebm2.4}
}
Kostenlos starten →